Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VNDA | US
-0.11
-1.50%
Healthcare
Biotechnology
30/06/2024
10/04/2026
7.22
7.35
7.35
7.06
Vanda Pharmaceuticals Inc. a biopharmaceutical company focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder insomnia delayed sleep phase disorder sleep disturbances in autism spectrum disorder and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686) a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis motion sickness atopic dermatitis and COVID-19 pneumonia. The company's pipeline products also include VTR-297 a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765 a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896 an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington the District of Columbia.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak Operating Margin (< 10%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.6%1 month
73.4%3 months
112.3%6 months
106.9%-
30.30
0.53
0.02
0.01
12.91
0.59
-2.42
-26.54M
420.85M
420.85M
-
-20.10
-95.90
9.60
-2.02
5.68
7.05
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.22
Range1M
3.09
Range3M
4.21
Rel. volume
0.48
Price X volume
6.17M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics Inc | ESPR | Biotechnology | 2.17 | 440.42M | -0.46% | n/a | -161.71% |
| REGENXBIO Inc | RGNX | Biotechnology | 8.8 | 434.92M | -1.79% | n/a | 45.57% |
| XOMA Corporation | XOMA | Biotechnology | 36.74 | 430.02M | -0.05% | n/a | 121.93% |
| Emergent BioSolutions Inc | EBS | Biotechnology | 7.96 | 421.14M | -5.80% | n/a | 226.97% |
| KEROS THERAPEUTICS INC. | KROS | Biotechnology | 11.205 | 420.44M | -10.29% | n/a | 3.32% |
| CorMedix Inc | CRMD | Biotechnology | 7.24 | 418.19M | -1.63% | n/a | 1.29% |
| Adlai Nortye Ltd. | ANL | Biotechnology | 11.16 | 411.81M | -7.00% | n/a | 72.87% |
| Autolus Therapeutics Plc | AUTL | Biotechnology | 1.49 | 396.48M | 1.36% | n/a | 54.69% |
| PureTech Health plc | PRTC | Biotechnology | 16.5 | 395.04M | 0.36% | n/a | 39.49% |
| Puma Biotechnology Inc | PBYI | Biotechnology | 7.78 | 381.58M | -0.26% | 15.16 | 203.23% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 21.52 | 357.39M | -0.37% | 34.27 | 26.82% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 7.29 | 328.99M | 1.82% | n/a | 3644.76% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.01 | 288.35M | 3.79% | n/a | 174.23% |
| Urban One Inc | UONEK | Broadcasting - Radio | 5.2301 | 277.24M | 0.00% | n/a | 268.43% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.46 | 258.99M | -0.53% | 13.23 | 0.00% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 17.43 | 194.48M | 2.29% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 10.06 | 161.53M | -1.08% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.925 | 100.30M | 2.42% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.62 | 91.55M | 1.81% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.78 | 73.76M | 1.38% | 14.48 | 7.10% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 12.91 | - | Expensive |
| Ent. to Revenue | 0.59 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.53 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 112.25 | - | Riskier |
| Debt to Equity | 0.02 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 420.85M | - | Emerging |